Recall of TPHA kit

According to L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), this recall involved a device in France that was produced by EUROBIO.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
  • Date
  • Event Country
  • Event Source
  • Event Source URL
  • Notes / Alerts
    French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
  • Extra notes in the data
  • Action
    Eurobio withdraws 604465 (January 01, 2005) from the market for the in vitro diagnostic medical device known as: TPHA kit - reference SHASYP00-8T, following the presence of agglutinates in certain test red cell suspension vials, resulting in loss of sensitivity that can lead to false negative results. As a precautionary measure, in agreement with Afssaps, Eurobio asks biologists to reconsider all syphilis serodiagnostics concerned by this batch (present on the French market since September 10, 2003). A note. : in the case of a negative test, the notice advises to complete the profile of the results by practicing a RPR / VDRL-Coal on the sample. This device allows the detection and the titration of the antibodies anti-Treponema pallidum within the framework serodiagnosis of syphilis.


  • Model / Serial
  • Product Description
  • Manufacturer


  • Source